fluoromisonidazole has been researched along with Brain Neoplasms in 33 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (3.03) | 18.2507 |
| 2000's | 6 (18.18) | 29.6817 |
| 2010's | 22 (66.67) | 24.3611 |
| 2020's | 4 (12.12) | 2.80 |
| Authors | Studies |
|---|---|
| Arakawa, Y; Fushimi, Y; Nakamoto, Y; Sakata, A; Shimizu, Y | 1 |
| Akasaki, Y; Fukasawa, N; Miyake, K; Murayama, Y; Ogawa, D; Shimoda, M; Suzuki, K; Suzuki, T; Takei, J; Tanaka, T; Yamamoto, Y | 1 |
| Arakawa, Y; Fushimi, Y; Hinoda, T; Ishimori, T; Mineharu, Y; Nakajima, S; Nakamoto, Y; Okuchi, S; Oshima, S; Otani, S; Sakata, A; Sano, K; Shimizu, Y; Tanji, M; Wang, Y; Yoshida, K | 1 |
| Abdo, RA; Bentourkia, M; Fernandez, P; Lamare, F | 1 |
| Brenner, AJ; Clarke, GD; Floyd, JR; Fox, PT; Huang, S; Hyun, H; Jerabek, PA; Lee, EQ; Michalek, JE; Muzi, M; Reardon, DA; Schmainda, KM; Wen, PY | 1 |
| Barré, L; Bekaert, L; Bernaudin, M; Bordji, K; Branger, P; Collet, S; Constans, JM; Emery, E; Guillamo, JS; Lechapt-Zalcman, E; Levallet, G; Manrique, A; Petit, E; Ponte, K; Valable, S | 1 |
| Hatazawa, J; Hiraka, T; Hosoya, T; Kanoto, M; Kirii, K; Matsuda, K; Sakurada, K; Sonoda, Y; Sugai, Y; Toyoguchi, Y | 1 |
| Al Jaberi, M; Förster, S; Gempt, J; Göttler, J; Kluge, A; Lukas, M; Meyer, B; Preibisch, C; Pyka, T; Ringel, F; Schlegel, J; Shi, K; Wiestler, B; Zimmer, C | 1 |
| Barré, L; Bernaudin, M; Chakhoyan, A; Collet, S; Constans, JM; Delcroix, N; Guillamo, JS; Kauffmann, F; Lechapt-Zalcman, E; MacKenzie, ET; Petit, E; Touzani, O; Valable, S | 1 |
| Andronesi, OC; Barboriak, D; Ellingson, B; Fink, J; Gerstner, ER; Greco, E; Hanna, L; Kim, D; Kostakoglu, L; Mankoff, D; Mintz, A; Muzi, M; Prah, M; Ratai, EM; Richards, T; Schmainda, K; Sorensen, G; Zhang, Z | 1 |
| Hirata, K; Houkin, K; Kobayashi, H; Shiga, T; Terasaka, S; Yamaguchi, S | 1 |
| Gambrell, JV; Mistry, N; Quarles, CC; Stokes, AM | 1 |
| Cao, WD; Haba, R; Kawai, N; Lin, W; Maeda, Y; Miyake, K; Nishiyama, Y; Ogawa, D; Tamiya, T; Yamamoto, Y | 1 |
| Hawkins-Daarud, AJ; Hendrickson, K; Jacobs, J; Kinahan, P; Krohn, KA; Mrugala, MM; Neal, ML; Rockhill, JK; Rockne, RC; Swanson, KR; Trister, AD | 1 |
| Fink, JR; Krohn, KA; Mankoff, DA; McLaughlin, LJ; Muzi, JP; Muzi, M; O'Sullivan, JN; Peterson, LM; Rajendran, JG | 1 |
| Hatanaka, KC; Hirata, K; Kobayashi, H; Kobayashi, K; Kuge, Y; Manabe, O; Shiga, T; Tamaki, N; Terasaka, S; Toyonaga, T; Watanabe, S; Yamaguchi, S; Yuzawa, S | 1 |
| Barboriak, DP; Eikman, EA; Ellingson, BM; Fink, JR; Gerstner, ER; Greco, E; Hanna, L; Kostakoglu, L; Mankoff, DA; Mintz, A; Muzi, M; Prah, M; Ratai, EM; Schmainda, KM; Sorensen, AG; Zhang, Z | 1 |
| Hattori, N; Hirata, K; Ito, YM; Kobayashi, H; Kobayashi, K; Kuge, Y; Manabe, O; Shiga, T; Tamaki, N; Tanaka, S; Terasaka, S; Toyonaga, T; Watanabe, S; Yamaguchi, S | 1 |
| Hirata, K; Houkin, K; Ishi, Y; Kobayashi, H; Kobayashi, K; Motegi, H; Shiga, T; Tamaki, N; Terasaka, S; Toyonaga, T; Yamaguchi, S | 1 |
| Alvord, EC; Chakraborty, G; Hadley, J; Krohn, KA; Muzi, M; Rockne, R; Spence, AM; Swanson, KR; Szeto, MD | 1 |
| Kawai, N; Kudomi, N; Maeda, Y; Miyake, K; Nishiyama, Y; Okada, M; Tamiya, T; Yamamoto, Y | 1 |
| Alessio, AM; Alvord, EC; Anderson, AR; Chakraborty, G; Champley, K; Claridge, J; Gu, S; Kinahan, PE; Krohn, KA; Muzi, M; Rockne, R; Spence, AM; Swanson, KR | 1 |
| Barré, L; Bernaudin, M; Delamare, J; Divoux, D; Marteau, L; Petit, E; Roussel, S; Sobrio, F; Toutain, J; Valable, S | 1 |
| Hattori, N; Hirata, K; Houkin, K; Kobayashi, H; Kuge, Y; Magota, K; Shiga, T; Tamaki, N; Tanaka, S; Terasaka, S; Yamaguchi, S | 1 |
| Aga, F; Kawai, N; Kudomi, N; Maeda, Y; Nishiyama, Y; Ono, Y; Yamamoto, Y | 1 |
| Katoh, N; Kuge, Y; Okamoto, S; Onimaru, R; Shiga, T; Shirato, H; Suzuki, R; Takeuchi, W; Tamaki, N; Tsuchiya, K; Yasuda, K | 1 |
| Hanzawa, H; Hatano, T; Kuge, Y; Kuno, N; Nishijima, K; Sakamoto, T; Tamaki, N; Zhao, S; Zhao, Y | 1 |
| Ametamey, SM; Bruehlmeier, M; Roelcke, U; Schubiger, PA | 1 |
| Berlangieri, SU; Cher, LM; Fabinyi, G; Hannah, A; Lawrentschuk, N; Murone, C; O'Keefe, GJ; Papenfuss, A; Ramdave, S; Sachinidis, JI; Scott, AM | 1 |
| Lee, ST; Scott, AM | 1 |
| Adamsen, TC; Krohn, KA; Link, JM; Muzi, M; O'Sullivan, F; Rajendran, JG; Rockhill, JK; Rostomily, RC; Silbergeld, DL; Spence, AM; Swanson, KR; Swanson, PE; Yagle, KJ | 1 |
| Chan, F; Chan, JG; Cher, L; Hall, C; Hill, J; Kaye, A; Sachinidis, JI; Scott, AM; Stylli, S; Tochon-Danguy, HJ | 1 |
| Budinger, TF; Gilbert, JC; Mathis, CA; Prados, MD; Valk, PE | 1 |
2 review(s) available for fluoromisonidazole and Brain Neoplasms
| Article | Year |
|---|---|
Usefulness of FMISO-PET for glioma analysis.
Topics: Adult; Animals; Brain Neoplasms; Diagnosis, Differential; Fluorine Radioisotopes; Glioblastoma; Glioma; Humans; Misonidazole; Oxygen; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results | 2013 |
Hypoxia positron emission tomography imaging with 18f-fluoromisonidazole.
Topics: Animals; Brain Ischemia; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Cell Hypoxia; Fluorine Radioisotopes; Glioma; Head and Neck Neoplasms; Humans; Lung Neoplasms; Misonidazole; Myocardial Ischemia; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Stroke | 2007 |
7 trial(s) available for fluoromisonidazole and Brain Neoplasms
| Article | Year |
|---|---|
Analysis of hypoxia in human glioblastoma tumors with dynamic 18F-FMISO PET imaging.
Topics: Brain Neoplasms; Carotid Artery, Common; Glioblastoma; Humans; Image Processing, Computer-Assisted; Misonidazole; Positron-Emission Tomography; Time Factors; Tumor Burden; Tumor Hypoxia | 2019 |
[18F]-FMISO PET study of hypoxia in gliomas before surgery: correlation with molecular markers of hypoxia and angiogenesis.
Topics: Adult; Aged; Aged, 80 and over; Biological Transport; Biomarkers, Tumor; Brain Neoplasms; Cerebral Blood Volume; Disease-Free Survival; Female; Glioma; Humans; Male; Middle Aged; Misonidazole; Neovascularization, Pathologic; Positron-Emission Tomography; Radiosurgery; Tumor Hypoxia | 2017 |
ACRIN 6684: Multicenter, phase II assessment of tumor hypoxia in newly diagnosed glioblastoma using magnetic resonance spectroscopy.
Topics: Aged; Brain; Brain Neoplasms; Female; Glioblastoma; Humans; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Male; Middle Aged; Misonidazole; Positron-Emission Tomography; Prognosis; Proton Magnetic Resonance Spectroscopy; Radiopharmaceuticals; ROC Curve; Tumor Hypoxia | 2018 |
Correlation of biological aggressiveness assessed by 11C-methionine PET and hypoxic burden assessed by 18F-fluoromisonidazole PET in newly diagnosed glioblastoma.
Topics: Adult; Aged; Brain Neoplasms; Cell Hypoxia; Female; Glioblastoma; Humans; Male; Methionine; Middle Aged; Misonidazole; Positron-Emission Tomography; Tumor Burden | 2011 |
¹⁸F-Fluoromisonidazole positron emission tomography may differentiate glioblastoma multiforme from less malignant gliomas.
Topics: Adult; Aged; Anaplasia; Biological Transport; Brain Neoplasms; Diagnosis, Differential; Female; Glioblastoma; Glioma; Humans; Male; Middle Aged; Misonidazole; Neoplasm Grading; Positron-Emission Tomography | 2012 |
Assessment of hypoxia and perfusion in human brain tumors using PET with 18F-fluoromisonidazole and 15O-H2O.
Topics: Adult; Aged; Blood Flow Velocity; Brain; Brain Neoplasms; Female; Humans; Hypoxia, Brain; Male; Middle Aged; Misonidazole; Oxygen Radioisotopes; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Water | 2004 |
Correlation of hypoxic cell fraction and angiogenesis with glucose metabolic rate in gliomas using 18F-fluoromisonidazole, 18F-FDG PET, and immunohistochemical studies.
Topics: Adult; Aged; Brain; Brain Neoplasms; Cell Hypoxia; Female; Fluorodeoxyglucose F18; Glioma; Glucose; Humans; Male; Metabolic Clearance Rate; Middle Aged; Misonidazole; Neovascularization, Pathologic; Oxygen; Radionuclide Imaging; Radiopharmaceuticals; Statistics as Topic | 2006 |
24 other study(ies) available for fluoromisonidazole and Brain Neoplasms
| Article | Year |
|---|---|
18 F-FMISO PET of an Intracranial Tuberculoma : A Great Mimicker.
Topics: Brain Neoplasms; Humans; Misonidazole; Positron Emission Tomography Computed Tomography; Tuberculoma, Intracranial; Tuberculosis | 2023 |
Topics: B7-H1 Antigen; Bevacizumab; Brain Neoplasms; Glioblastoma; Humans; Immunohistochemistry; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Tumor Microenvironment | 2023 |
Evaluation of isocitrate dehydrogenase mutation in 2021 world health organization classification grade 3 and 4 glioma adult-type diffuse gliomas with 18F-fluoromisonidazole PET.
Topics: Adult; Brain Neoplasms; Glioma; Humans; Isocitrate Dehydrogenase; Mutation; Positron-Emission Tomography; Prospective Studies; Retrospective Studies; World Health Organization | 2023 |
Assessment of tumor hypoxia and perfusion in recurrent glioblastoma following bevacizumab failure using MRI and
Topics: Adult; Aged; Bevacizumab; Biomarkers, Pharmacological; Brain Neoplasms; Cerebral Blood Volume; Drug Resistance, Neoplasm; Female; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Misonidazole; Neoplasm Recurrence, Local; Positron-Emission Tomography; Progression-Free Survival; Tumor Hypoxia; Young Adult | 2021 |
Correlation between hypoxic area in primary brain tumors and WHO grade: differentiation from malignancy using 18F-fluoromisonidazole positron emission tomography.
Topics: Brain Neoplasms; Cerebellum; Female; Humans; Male; Middle Aged; Misonidazole; Positron-Emission Tomography; Sensitivity and Specificity; Tumor Hypoxia | 2018 |
Characterizing hypoxia in human glioma: A simultaneous multimodal MRI and PET study.
Topics: Aged; Brain Neoplasms; Cell Hypoxia; Female; Glioma; Humans; Image Enhancement; Immunohistochemistry; Magnetic Resonance Imaging; Male; Middle Aged; Misonidazole; Positron-Emission Tomography | 2017 |
FMISO-PET-derived brain oxygen tension maps: application to glioblastoma and less aggressive gliomas.
Topics: Adult; Aged; Brain Mapping; Brain Neoplasms; Female; Glioblastoma; Gray Matter; Humans; Hypoxia, Brain; Male; Middle Aged; Misonidazole; Perfusion Imaging; Positron Emission Tomography Computed Tomography; Prospective Studies; ROC Curve; White Matter | 2017 |
Nitrite induces the extravasation of iron oxide nanoparticles in hypoxic tumor tissue.
Topics: Animals; Brain Neoplasms; Cell Hypoxia; Cell Line, Tumor; Extravasation of Diagnostic and Therapeutic Materials; Ferric Compounds; Misonidazole; Nanoparticles; Nitrites; Positron-Emission Tomography; Rats; Rats, Wistar; Time Factors | 2014 |
Correlation between ¹⁸F-fluoromisonidazole PET and expression of HIF-1α and VEGF in newly diagnosed and recurrent malignant gliomas.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Brain Neoplasms; Child; Female; Glioma; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Middle Aged; Misonidazole; Positron-Emission Tomography; Radiopharmaceuticals; Vascular Endothelial Growth Factor A | 2014 |
A patient-specific computational model of hypoxia-modulated radiation resistance in glioblastoma using 18F-FMISO-PET.
Topics: Aged; Brain Neoplasms; Glioma; Humans; Hypoxia; Male; Misonidazole; Models, Biological; Positron-Emission Tomography; Precision Medicine; Radiation-Sensitizing Agents; Radiography | 2015 |
18F-Fluoromisonidazole Quantification of Hypoxia in Human Cancer Patients Using Image-Derived Blood Surrogate Tissue Reference Regions.
Topics: Adult; Aged; Aged, 80 and over; Aorta; Brain Neoplasms; Cerebellum; Disease Progression; Female; Heart; Humans; Hypoxia; Kaplan-Meier Estimate; Magnetic Resonance Imaging; Male; Middle Aged; Misonidazole; Neoplasms; Oxygen; Positron-Emission Tomography; Predictive Value of Tests; Proportional Hazards Models; Radiopharmaceuticals; Tissue Distribution; Treatment Outcome | 2015 |
(18)F-fluoromisonidazole positron emission tomography can predict pathological necrosis of brain tumors.
Topics: Adult; Aged; Aged, 80 and over; Brain Neoplasms; Cerebellum; Female; Humans; Male; Middle Aged; Misonidazole; Necrosis; Positron-Emission Tomography | 2016 |
ACRIN 6684: Assessment of Tumor Hypoxia in Newly Diagnosed Glioblastoma Using 18F-FMISO PET and MRI.
Topics: Adult; Aged; Biomarkers; Brain Neoplasms; Disease-Free Survival; Female; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Misonidazole; Neovascularization, Pathologic; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tumor Hypoxia | 2016 |
Hypoxic glucose metabolism in glioblastoma as a potential prognostic factor.
Topics: Adult; Aged; Blood Glucose; Brain Neoplasms; Cell Hypoxia; Female; Fluorodeoxyglucose F18; Glioblastoma; Glycolysis; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Misonidazole; Oxygen; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2017 |
Change in 18F-Fluoromisonidazole PET Is an Early Predictor of the Prognosis in the Patients with Recurrent High-Grade Glioma Receiving Bevacizumab Treatment.
Topics: Adult; Aged; Antineoplastic Agents; Bevacizumab; Brain Neoplasms; Glioma; Humans; Magnetic Resonance Imaging; Middle Aged; Misonidazole; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2016 |
Quantitative metrics of net proliferation and invasion link biological aggressiveness assessed by MRI with hypoxia assessed by FMISO-PET in newly diagnosed glioblastomas.
Topics: Adult; Brain Neoplasms; Cell Division; Computer Simulation; Contrast Media; Female; Fluorine Radioisotopes; Gadolinium; Glioblastoma; Humans; Image Enhancement; Magnetic Resonance Imaging; Middle Aged; Misonidazole; Neoplasm Invasiveness; Positron-Emission Tomography | 2009 |
Applying a patient-specific bio-mathematical model of glioma growth to develop virtual [18F]-FMISO-PET images.
Topics: Adult; Brain Neoplasms; Cell Proliferation; Computer Simulation; Fluorine Radioisotopes; Glioblastoma; Glioma; Humans; Hypoxia; Image Interpretation, Computer-Assisted; Male; Mathematical Concepts; Misonidazole; Models, Biological; Necrosis; Neoplasm Invasiveness; Neovascularization, Pathologic; Positron-Emission Tomography; Precision Medicine; Radiopharmaceuticals; User-Computer Interface | 2012 |
Complementary information from magnetic resonance imaging and (18)F-fluoromisonidazole positron emission tomography in the assessment of the response to an antiangiogenic treatment in a rat brain tumor model.
Topics: Angiogenesis Inhibitors; Animals; Biological Transport; Brain; Brain Neoplasms; Cell Hypoxia; Cell Line, Tumor; Cerebrovascular Circulation; Disease Models, Animal; Glioma; Indoles; Kinetics; Magnetic Resonance Imaging; Misonidazole; Neovascularization, Pathologic; Permeability; Positron-Emission Tomography; Pyrroles; Rats; Sunitinib; Treatment Outcome | 2011 |
Hypoxia assessed by 18F-fluoromisonidazole positron emission tomography in newly diagnosed gliomas.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Brain Neoplasms; Child; Child, Preschool; Female; Glioma; Humans; Hypoxia; Male; Middle Aged; Misonidazole; Positron-Emission Tomography; Radiation-Sensitizing Agents; Retrospective Studies; Young Adult | 2012 |
[18F]fluoromisonidazole and a new PET system with semiconductor detectors and a depth of interaction system for intensity modulated radiation therapy for nasopharyngeal cancer.
Topics: Adult; Aged; Aged, 80 and over; Brain Neoplasms; Case-Control Studies; Cell Hypoxia; Female; Humans; Laryngeal Neoplasms; Lutetium; Male; Middle Aged; Misonidazole; Mouth Neoplasms; Multimodal Imaging; Nasopharyngeal Neoplasms; Nasopharynx; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Image-Guided; Radiotherapy, Intensity-Modulated; Semiconductors; Silicates; Thyroid Neoplasms; Tomography, X-Ray Computed | 2013 |
Biological characteristics of intratumoral [F-18]‑fluoromisonidazole distribution in a rodent model of glioma.
Topics: Animals; Autoradiography; Biological Transport; Brain Neoplasms; Cell Hypoxia; Cell Proliferation; Fluorodeoxyglucose F18; Glioma; Glucose; Glucose Transporter Type 1; Hexokinase; Hypoxia-Inducible Factor 1; Ki-67 Antigen; Male; Misonidazole; Nitroimidazoles; Rats; Rats, Wistar; Tissue Distribution | 2013 |
Regional hypoxia in glioblastoma multiforme quantified with [18F]fluoromisonidazole positron emission tomography before radiotherapy: correlation with time to progression and survival.
Topics: Adult; Aged; Brain Neoplasms; Cell Hypoxia; Disease Progression; Female; Glioblastoma; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Misonidazole; Positron-Emission Tomography; Regression Analysis | 2008 |
Imaging and quantitation of the hypoxic cell fraction of viable tumor in an animal model of intracerebral high grade glioma using [18F]fluoromisonidazole (FMISO).
Topics: Animals; Brain Neoplasms; Cell Hypoxia; Fluorine Radioisotopes; Glioma; Intestinal Mucosa; Kidney; Liver; Male; Misonidazole; Rats; Rats, Wistar; Tissue Distribution; Tomography, Emission-Computed | 2002 |
Hypoxia in human gliomas: demonstration by PET with fluorine-18-fluoromisonidazole.
Topics: Adult; Astrocytoma; Brain Neoplasms; Cell Hypoxia; Fluorine Radioisotopes; Glioblastoma; Humans; Male; Middle Aged; Misonidazole; Tomography, Emission-Computed | 1992 |